Is a 3-month course of treatment with peg-interferon effective in acute HCV hepatitis?

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 2, 2003, Pages 188-190

  Cariti, Giuseppe ^a   Quaglia, S ^a   Meoli, I ^a   Veronese, L ^a   Audagnotto, S ^a   De Blasi, T ^a   Mancardi, E ^a   Raiteri, R ^a   Di Perri, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute hepatitis; HCV; Pegylated interferon; Progression rate

Indexed keywords

ALANINE AMINOTRANSFERASE; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; MALE; PATIENT REFERRAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT; SYMPTOMATOLOGY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0141615986     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Seef LB. Natural history of chronic hepatitis C. Hepatology 2002; 36 (Suppl.): S35-46.
2. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (Suppl.): S21-9.
3. Manns MP, McHutchison JG, Gordon SC, et al. PegInterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomized trial. Lancet 2001; 358: 958-65.
4. Alberti A, Boccato S, Vario A, Benvegnù L. Therapy of acute hepatitits. Hepatology 2002; 36 (Suppl.): S195-200.
5. Jaeckel E, Cornberg M, Wedermeyer H, et al. Treatment of acute hepatitis C with Interferon alfa;2b. NEJM 2001; 345: 1452-7.
6. Orland JR, Wright T, Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321-7.
7. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 10: 1395-406.
8. Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 1999; 117: 933-41.
9. Chang KM, Thimme R, Mepolder J, et al. Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33: 267-73.
10. Urbani S, Boni C, Missale G, et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exibit functional differences in acute hepatitis B and C. J Virol 2002; 76: 12423-34.